Product
IFX-1 + BSC
1 clinical trial
1 indication
Indication
COVID-19 pneumoniaClinical trial
A Pragmatic Adaptive Randomized, Controlled Phase II/III Multicenter Study of IFX-1 in Patients With Severe COVID-19 PneumoniaStatus: Completed, Estimated PCD: 2021-10-31